{
  "run_id": "RUN_20260204_234342_996d5a3920e1",
  "timestamp": "2026-02-05T04:42:43.903516",
  "document": "Chronic-Granulomatous-Disease.pdf",
  "document_path": "/Users/frederictetard/Projects/ese/gold_data/NLP4RARE/train/Chronic-Granulomatous-Disease.pdf",
  "pipeline_version": "0.8",
  "total_recommendation_sets": 1,
  "total_recommendations": 2,
  "recommendation_sets": [
    {
      "guideline_name": "Clinical diagnostic procedures for chronic granulomatous disease",
      "guideline_year": null,
      "organization": "Not specified",
      "target_condition": "chronic granulomatous disease",
      "target_population": null,
      "recommendations": [
        {
          "recommendation_id": "rec_Chronic-Granulomatous-Disease_1",
          "recommendation_type": "treatment",
          "population": "individuals suspected of having chronic granulomatous disease",
          "condition": "suspected CGD",
          "severity": "not specified",
          "action": "perform dihydrorhodamine 123 (DHR) test to measure oxidant production by white blood cells",
          "action_description": null,
          "preferred": "dihydrorhodamine 123 (DHR) test",
          "alternatives": [
            "nitroblue tetrazolium (NBT) slide test"
          ],
          "dosing": [],
          "taper_target": "not applicable",
          "duration": "not specified",
          "stop_window": null,
          "evidence_level": "expert_opinion",
          "strength": "conditional",
          "references": [],
          "source": "Chronic-Granulomatous-Disease",
          "source_text": "One blood test for diagnosis of CGD uses a molecule called dihydrorhodamine 123 (DHR) to determine whether or not white blood cells are making these oxidants normally.",
          "page_num": null
        },
        {
          "recommendation_id": "rec_Chronic-Granulomatous-Disease_2",
          "recommendation_type": "treatment",
          "population": "patients diagnosed with CGD based on defects in blood cell oxidant production",
          "condition": "confirmed CGD",
          "severity": "not specified",
          "action": "perform genetic testing to determine the specific type of CGD",
          "action_description": null,
          "preferred": "genetic testing",
          "alternatives": [],
          "dosing": [],
          "taper_target": "not applicable",
          "duration": "not specified",
          "stop_window": null,
          "evidence_level": "expert_opinion",
          "strength": "conditional",
          "references": [],
          "source": "Chronic-Granulomatous-Disease",
          "source_text": "If CGD is diagnosed based on defects in blood cell oxidant production, genetic testing is typically recommended to determine the specific type of CGD.",
          "page_num": null
        }
      ],
      "source_document": "Chronic-Granulomatous-Disease",
      "extraction_confidence": 0.85
    }
  ]
}